In September, Bloomberg reported that Sanofi had received two separate bids from CD&R and rival PAI Partners for the Opella unit. CD&R has kept away interest from rival PAI Partners for the unit ...

The French pharmaceutical group’s board is scheduled to meet to discuss the planned transaction and finalize measures with CD&R to protect jobs and local plants, the people said, asking not to ...

Clayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in what would be one of the largest European transactions this year ...

Most optical drives today are combo CD/DVD drives that support DVDs and all the CD formats: CD audio, CD-ROM, CD-R and CD-RW. The speeds of the drives are rated by their CD-ROM and DVD transfer rates.

The French finance ministry said in a statement that CD&R was a "serious investment fund" with positive prospects for Opella's development and its plants in France. It added that it would require ...

The sale of a controlling 50-percent stake in Opella to CD&R values the maker of France's leading painkiller, Doliprane, at 16 billion euros ($17.4 billion), Sanofi said. "Sanofi and CD&R announce ...

Sanofi's negotiations with CD&R show the Paris-based company is following a different path to exit the business, though. The company said Friday that it is in discussions with New York-based CD&R ...

Citi was advising CD&R on the sale, while Goldman Sachs and Morgan Stanley were sellside advisors. JPMorgan Chase & Co. advised France’s PAI Partners on a rival bid. It’s unclear whether the ...

Bloomberg previously reported PE firms CD&R and PAI Partners submitted bids before a recent deadline. The latest update comes after a report from Bloomberg last week that potential bidders for ...

(Reuters) -Sanofi is closing in on a deal to sell its consumer health unit for about 15 billion euros ($16.4 billion) to U.S. private equity firm Clayton Dubilier & Rice (CD&R), a person familiar ...

A representative for Sanofi wasn’t available for comment. Representatives for CD&R and PAI Partners declined to comment. A deal would cap a yearlong effort by Sanofi to split its consumer health ...